Eudaimonia Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$291K Buy
2,208
+123
+6% +$15.1K 0.07% 202
2023
Q4
$301K Buy
2,085
+66
+3% +$9.06K 0.08% 187
2023
Q3
$343K Buy
2,019
+200
+11% +$39.8K 0.08% 217
2023
Q2
$406K Sell
1,819
-25
-1% -$5.11K 0.09% 208
2023
Q1
$408K Sell
1,844
-569
-24% -$140K 0.1% 210
2022
Q4
$523K Buy
2,413
+32
+1% +$8.53K 0.13% 172
2022
Q3
$630K Buy
2,381
+469
+25% +$119K 0.16% 143
2022
Q2
$400K Sell
1,912
-2,027
-51% -$452K 0.07% 251
2022
Q1
$871K Buy
+3,939
New +$832K 0.15% 168
2021
Q3
$795K Buy
3,629
+2,099
+137% +$448K 0.14% 172
2021
Q2
$258K Sell
1,530
-3,347
-69% -$540K 0.05% 326
2021
Q1
$712K Sell
4,877
-427
-8% -$68.5K 0.15% 157
2020
Q4
$783K Buy
5,304
+210
+4% +$24.9K 0.18% 136
2020
Q3
$455K Buy
5,094
+64
+1% +$5.67K 0.12% 186
2020
Q2
$388K Buy
5,030
+3,984
+381% +$271K 0.15% 154
2020
Q1
$59K Buy
1,046
+71
+7% +$5.44K 0.03% 423
2019
Q4
$71K Buy
+975
New +$65.1K 0.03% 416

Other funds holding ALB

Eudaimonia Partners's ALB Position: Q1 2024 in Review

Eudaimonia Partners increased its Albemarle (ALB) stake by 5.9% in Q1 2024, buying an estimated $15.1K and bringing the position to 2,208 shares worth $291K. The position accounts for 0.07% of the portfolio, ranked #202.

Eudaimonia Partners first reported a position in ALB in Q4 2019 and has held it in 17 quarters since. The position peaked at $871K in Q1 2022. 916 funds tracked by Wall St. Rank hold ALB as of Q1 2024.

  • Eudaimonia Partners held 2,208 shares of Albemarle worth $291K as of Q1 2024.
  • Eudaimonia Partners bought 123 Albemarle shares in Q1 2024, an estimated $15.1K.
  • Albemarle made up 0.07% of Eudaimonia Partners's portfolio in Q1 2024, its #202 holding.
  • Eudaimonia Partners first reported a position in Albemarle in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Albemarle position peaked at $871K in Q1 2022.
  • 916 funds tracked by Wall St. Rank held Albemarle as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.